Publications by authors named "Matthieu Gregoire"

Claim this Profile
E
Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections.
Eva Benavent, Jaime Lora-Tamayo, Marta Ulldemolins, Paula Pons-Oltra, Matthieu Gregoire

Antimicrob Agents Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of cerebral vasospasm therapy on nimodipine exposure in subarachnoid hemorrhage: A population pharmacokinetic study.
Adrien Foucher, Matthieu Gregoire, Jérôme E Dauvergne, Elodie Boissier, Bertrand Rozec

J Neurol Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting prolonged dalbavancin exposure using machine learning: a validated strategy for individualized redosing.
Hamza Sayadi, Matthieu Gregoire, Yeleen Fromage, Mohamed Ksentini, Marc Labriffe

Antimicrob Agents Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review.
Anne Coste, Cécile Aubron, Séverine Ansart, Jason Roberts, Florent Morio

Crit Care· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A priori optimization of levofloxacin dose regimen based on a population pharmacokinetics model.
Emmanuel Enard, Matthieu Grégoire, Éric Dailly, Ronan Le Floch, Karim Lakhal

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortium.
Jean-Baptiste Woillard, Sébastien Benzekry, Julie Josse, Mélanie White-Koning, Etienne Chatelut, Matthieu Gregoire

Therapie· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing addiction care: Benefits of urinary screening with LC-HRMS (liquid chromatography-high resolution mass spectrometry) for psychoactive substances and drugs.
Edouard Le Carpentier, Morgane Helesbeux, Vanessa Biering, Aurélie Aquizerate, Morgane Rousselet

Prog Neuropsychopharmacol Biol Psychiatry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With Human Immunodeficiency Virus Type 1: First Results From the ANRS-MIE CARLAPOP Study.
Nadège Néant, Minh P Lê, Stéphane Bouchet, Jennifer Lagoutte-Renosi, Matthieu Grégoire

Clin Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir.
Florian Lemaitre, Lidvine Boland, Camille Tron, Matthieu Grégoire, Véronique Lelong-Boulouard

Therapie· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Place Is There for Long-Acting Antibiotics in the Management of Gram-Positive Infections? A Qualitative Cross-Sectional Study.
Aurélien Dinh, Guillaume Béraud, Johan Courjon, Yann Le Goff, Nicolas Kader Ettahar

Antibiotics (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
Florian Lemaitre, Jennifer Lagoutte-Renosi, Marie-Claude Gagnieu, François Parant, Nicolas Venisse

Br J Clin Pharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.
Charles Hervochon, Benjamin Hennart, Anne-Gaëlle Leroy, Stéphane Corvec, David Boutoille, Matthieu Gregoire

J Antimicrob Chemother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel.
Eric Senneville, Guillermo Cuervo, Matthieu Gregoire, Carmen Hidalgo-Tenorio, François Jehl

Int J Antimicrob Agents· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series Analysis.
Arnaud Callies, Lise Martin-Perceval, Lise Crémet, Lilas Gély, Anne-Lise Ruellan, Matthieu Gregoire

Pediatr Infect Dis J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections-a monocentre quality improvement project.
Cecile Lagarde, Marwan Bouras, Ronan Le Floch, Yannick Hourmant, Nicolas Grillot, Matthieu Gregoire

J Antimicrob Chemother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis.
Ronan Bellouard, Antoine Rambaud, Clarisse Delaunay, Éric Dailly, Raphaël Lecomte

J Antimicrob Chemother· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
Sihem Benaboud, Caroline Solas, Stephane Bouchet, Matthieu Gregoire, Florian Lemaitre

J Antimicrob Chemother· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suboptimal dalbavancin dosages in an adult with sickle-cell disease and glomerular hyperfiltration.
Salomé Abdellaoui, Matthieu Gregoire, Marie Dubert, Geoffrey Cheminet, Jean-Benoît Arlet

J Antimicrob Chemother· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to "CYP450 3A4/5 Containment During SARS-CoV-2 Infection".
Edouard Charles Le Carpentier, Emmanuel Canet, Damien Masson, Ronan Bellouard, Matthieu Grégoire

Clin Pharmacol Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring the activity of direct oral anticoagulants in a patient with severe nephrotic syndrome and pulmonary embolism. Lessons for the clinical nephrologist.
Manuel Laslandes, Jérôme Connault, Laurent Nicolet, Catherine Ternisien, Matthieu Gregoire

J Nephrol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach.
Anne Coste, Ronan Bellouard, Guillaume Deslandes, Laurence Jalin, Claire Roger

Antibiotics (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Inflammation on Midazolam Metabolism in Severe COVID-19 Patients.
Edouard Charles Le Carpentier, Emmanuel Canet, Damien Masson, Maëlle Martin, Guillaume Deslandes, Matthieu Gregoire

Clin Pharmacol Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT).
Florian Lemaitre, Matthieu Grégoire, Caroline Monchaud, Stéphane Bouchet, Béatrice Saint-Salvi

Therapie· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly Conserved Gene of Pneumocystis jirovecii in Patients with or without Prior Exposure to Echinocandins.
Pierre L Bonnet, Solène Le Gal, Claire V Hoffmann, Florent Morio, Fouleymata Diabira

Antimicrob Agents Chemother· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF concentration of cefotaxime in adult patients with pneumococcal meningitis: a multicentre retrospective study.
Paul Le Turnier, Najoua El Helali, Romain Guilhaumou, Benoit Pilmis, Matthieu Revest, Matthieu Gregoire

J Antimicrob Chemother· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis